Amarin Corp Plc (AMRN)

[couldbebetter]

iryokabu, Seems like the flood gates for generics to sell generic
Vascepa are open and only decisive action by the courts and/or the FDA
will stop it. (Most unlikely, in my opinion.) The generics may even
be allowed to offer a version that may not only be inferior to Vascepa,
but might actually be dangerous due to the product being rancid or
having unwanted elements such as DHA. If I were running AMRN I'd
fight the legal battle in any way that would diminish the will of the
generics to fight on. As part of such a strategy I would advertise
Vascepa with the warning that generic Vascepa may not be up to the same
standards as Vascepa and may not have the same medical benefit as the
branded Vascepa used in the Reduce-It study. (I would also give an
800 number suggesting an attorney if anyone believes they were harmed
by a generic Vascepa.) The point of this would be to scare anyone
culpable if an injury from generic Vascepa were to occur, that they
might decide it is not worth the risk. I would run Vascepa commercials
pointing out the differences between Vascepa and the generic. Bottom
line I would fight a guerilla war using attorneys to raise hell with
anyone who sells garbage that inures CVD patients.